If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Last Updated October 27, 2009

H1N1 Flu information

State of NH DHHS
WMUR Channel 9
Centers for Disease Control and Prevention

Mid-State is following the State of NH's Department of Health & Human Services guideline for vaccinating against H1N1

H1N1 vaccine will be given to the following groups in order of priority and based on availability of vaccine: 1 Medical conditions include but are not limited to: chronic renal, heart (except hypertension), liver, or lung disease (including asthma), cancer, immunosuppression (medication-induced or disease), cognitive, neuralgic/neuromuscular, hematologic, or metabolic disorders (including diabetes mellitus), sickle cell, cystic fibrosis, organ transplant, MS, or spinal cord injury.

2 Healthcare Worker: nurses, physicians, respiratory therapists, ancillary workers, students, and volunteers who have direct contact3 with patients or infectious respiratory material in acute care hospitals, long term care facilities, ambulatory care clinics, outpatient surgery clinics, dialysis centers, physician offices and home care agencies.

3 Direct patient contact: coming into close proximity (within 6 feet or in a hospital room) of a person ill with influenza-like illness (and/or their respiratory secretions) during the course of caring for or living with them. Close contact typically does not include activities such as walking by an infected person or sitting across from a symptomatic patient in a waiting room or office.

* Many persons who do not fit into these criteria may have some level of patient contact and would benefit from H1N1 vaccine. Given the limited early supply of vaccine, those with direct patient contact as defined above are prioritized, but within the coming weeks there will be sufficient supply for all health care workers, even those without direct patient contact.

H1N1 Vaccines:

Live attenuated influenza vaccine (nasal spray) Inactivated vaccine (injectable) Note: children under 10 years of age should receive 2 doses of H1N1 vaccine (live attenuated or inactivated vaccine) 28 days apart.

Vaccine contraindications: age <6 months, serious egg allergy, history of serious reaction to flu vaccine, history of Guillain-Barré Syndrome.

Simultaneous vaccination with H1N1 live attenuated vaccine and other live vaccines: Should a person who already had the flu be vaccinated? Yes, unless it was confirmed by RT-PCR or viral culture that the person had H1N1 influenza.
Take Our Customer Satisfaction Survey
Date of Visit:
Account #: